Skip to main content
Sébastien Barbarot on Muck Rack

Sébastien Barbarot

As seen in: Nature, Wiley Online Library, The Journal of Pediatrics, Annals of Allergy, Asthma & Immunology, Value in Health Journal, SKIN The Journal of Cutaneous Medicine
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Sébastien

Contact Sébastien, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

CO119 NATURAL HISTORY, MANAGEMENT, AND BURDEN OF DISEASE IN ADULTS WITH NF1 AND SYMPTOMATIC INOPERABLE PLEXIFORM NEUROFIBROMA IN FRANCE

|
By Laura Fertitta, Assistance Publique, Sébastien Barbarot
| Value in Health Journal Verified
1Assistance Publique - Hôpitaux de Paris, Department of Dermatology, National Referral Center for Neurofibromatoses, Henri Mondor Hospital, Créteil, France 2University Hospital of Nantes, Dermatology Department, Nantes, France 3Alexion, AstraZeneca Rare Disease, Global HEOR, Boston, MA, USA 4Alexion, AstraZeneca Rare Disease, Medical Metabolics, Paris, France 5IQVIA, Real World Solutions, Courbevoie, France 6Centre Léon Bérard, Department of Dermatology, Lyon, France
Open in Who Shared Issue with article?

Trametinib for multiple non-ossifying fibromas due to KRAS mosaic mutations: two case reports

|
By Marie Vincent, Alicia Besson, Sébastien Barbarot, Bertrand Isidor, Aymeric Rouchaud, Geneviève Baujat, Pierre Vabres, Patrick Edery, Massimiliano Rossi, Soizic Tiriau, Marine Fouillet-Desjonqueres, Wassim Ouchetto, Marion Delous
| Nature Verified
Abstract KRAS mosaic activating variants are the main cause of non-ossifying fibromas (NOFs), the most common benign lesion of the growing skeleton. Multifocal NOFs cause bone fragility, and no specific treatment is currently available.
Open in Who Shared Issue with article?

Public‐health implications of market drug withdrawals: A focus on antifungals for tinea capitis

|
By Annabel Maruani, Sébastien Barbarot, CHU Nantes, Sophie Leducq
| Wiley Online Library Verified
Public-health implications of market drug withdrawals: A focus on antifungals for tinea capitis On behalf of Centre of Evidence of the French Society of Dermatology, Paris, France.
Open in Who Shared Issue with article?
See all 11 articles